A detailed history of Oracle Alpha Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Oracle Alpha Inc. holds 1,915 shares of DXCM stock, worth $153,659. This represents 0.48% of its overall portfolio holdings.

Number of Shares
1,915
Previous 2,775 30.99%
Holding current value
$153,659
Previous $344 Million 22.87%
% of portfolio
0.48%
Previous 0.45%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$114.22 - $140.1 $98,229 - $120,486
-860 Reduced 30.99%
1,915 $266 Million
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $209,484 - $344,544
2,775 New
2,775 $344 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Oracle Alpha Inc. Portfolio

Follow Oracle Alpha Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Alpha Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oracle Alpha Inc. with notifications on news.